Practicality of <i>STAT3</i> Gene Polymorphisms and Sorafenib Trough Concentration as Biomarkers for Sorafenib-Induced Hand-Foot Skin Reaction in Hepatocellular Carcinoma

<div>Relationship between the sorafenib concentration on day 8 and HFSR onset (a) and severity (b). HFSR, hand-foot skin reaction; sorafenib <i>C</i><sub>day8</sub>, sorafenib concentration on day 8.</div>

Journal of Clinical Pharmacy and Therapeutics

fig2

Figure 2

Figure 2: Practicality of <i>STAT3</i> Gene Polymorphisms and Sorafenib Trough Concentration as Biomarkers for Sorafenib-Induced Hand-Foot Skin Reaction in Hepatocellular Carcinoma 

Figure 2 | Practicality of STAT3 Gene Polymorphisms and Sorafenib Trough Concentration as Biomarkers for Sorafenib-Induced Hand-Foot Skin Reaction in Hepatocellular Carcinoma 